Journal of Pharmaceutical Investigation

The Korean Society of Pharmaceutical Sciences and Technology (한국약제학회)
권호 표지
DOI QR코드

DOI QR Code

Current Pretreatment of Skin and Its Effect on the Permeability

전류 전처리의 경피 투과도에 미치는 효과

  • 이정화 (숙명여자대학교 약학대학) ;
  • 오승열 (숙명여자대학교 약학대학)
  • Published : 2005.04.20
Download PDF
⟨ Previous Next ⟩

Abstract

We have prepared karaya gum patches containing ketoprofen and investigated the effect of short-time current pretreatment of skin on the permeability. Hairless mouse skin was treated with current before the patch was mounted on the skin. The effect of current density and current duration on the flux of ketoprofen was studied. The possibility of additive effect with penetration enhancer (PGML) was also investigated. Iontophoretic pretreatment of skin increased the passive flux up to 3 folds at 0.4 $mA/cm^2$ current density, when the matrix contained no PGML. As the duration of current-pretreatment and current density increased, flux increased. PGML increased the average passive flux markedly, about 6 to 12 folds, depending on the concentration in the patch. Current pretreatment further increased the flux from this PGML containing patch, exhibiting additive effect. These results indicate that short-duration current pretreatment of skin can be an useful method for the enhancement of ketoprofen permeability through skin.

Keywords

References

  1. S. Chong, H.L. Fung, J. Hadgraft and R.H. Guy, Transdermal drug delivery systems: pharmacokinetics, clinical efficacy, and tolerance development : In Transdermal Drug Delivery, Developmental Issues and Research Initiatives, J. Hadgraft and R.H. Guy (Ed.), Marcel Dekker, New York, U.S.A., p 135 (1989)
  2. M.C. Audet, M. Moreau, W.D. Koltun, A.S. Waldbaum, G. Shangold, A.C Fisher and G.W.Creasy, Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs. an oral contraceptive: a randomized controlled trial, JAMA, 285(18), 2347-2354 (2001) https://doi.org/10.1001/jama.285.18.2347
  3. Electronic Orange Book, Food and Drug Administration, December 2004
  4. Retail and Provider Perspective, IMS Health, 2001
  5. E.F. Sherertz, K.B. Sloan and R.G. McTiernan, Transdermal delivery of 5-fluorouracil through skin of hairless mice and humans in vitro: a comparison of the effect of formulations and a prodrug, Arch. Dermatol. Res., 282(7), 463-468 (1990) https://doi.org/10.1007/BF00402624
  6. R.O. Potts, G.M. Golden, M.L. Francoeur, V.H.W. Mak and R.H. Guy, Mechanism and enhancement of solute transport across the stratum corneum, J. Controlled Release, 15, 249-260 (1991) https://doi.org/10.1016/0168-3659(91)90116-U
  7. M.J. Pikal, Transport mechanisms in iontophoresis. I. A theoretical model for the effect of electroosmotic flow on flux enhancement in transdermal iontophoresis, Pharm. Res., 7, 118-126 (1990) https://doi.org/10.1023/A:1015816532532
  8. H.A.E. Benson, J.C. McElnay, R. Harland and J. Hadgraft, Influence of ultrasound on the percutaneous absorption of nicotinate esters, Pharm. Res., 8, 204-209 (1991) https://doi.org/10.1023/A:1015892020468
  9. S.L. Chang, G.A. Hofmann, L. Zhang, L.J. Deftos and A.K. Banga, The effect of electroporation on iontophoretic transdermal delivery of calcium regulating hormones. J. Controlled Release, 66, 127-33 (2000) https://doi.org/10.1016/S0168-3659(99)00262-X
  10. S. Le Duc, Electric ions and their use in medicine, Rebman, London, England (1908)
  11. P.G. Green, R.S. Hinz, A. Kim, C. Cullander, G. Yamane, F.C. Szoka Jr. and R.H. Guy, Transdermal iontophoresis of amino acids and peptides ill vitro, J. Controlled Release, 21, 187-190 (1992) https://doi.org/10.1016/0168-3659(92)90020-R
  12. R.R. Bumette, J. Hadgraft and R.H. Guy, Iontophoresis: In Transdermal Drug Delivery, R.H. Guy and J. Hadgraft (Ed.), Marcel Dekker Inc., New York, U.S.A., 247-291 (1989)
  13. G. Hritzo, Management of postsurgical hyperhidrosis with direct current and tap water: a case report, J. Hand Ther., 17, 42 (2004)
  14. P.M. Farrell and R.E. Koscik, Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis, Pediatrics, 97, 524-528 (1996)
  15. W.T. Zempsky and T.M. Parkinson, Lidocaine iontophoresis for topical anesthesia before dermatologic procedures in children: a randomized controlled trial, Pediatr. Dermatol., 20, 364 (2003) https://doi.org/10.1046/j.1525-1470.2003.20421.x
  16. M.A. Ashburn, J. Streisand, J. Zhang, G. Love, M. Rowin, S. Niu, J.K. Kievit, J.R. Kroep and M.J. Mertens, The iontophoresis of fentanyl citrate in humans, Anesthesiology, 82, 1146-53 (1995) https://doi.org/10.1097/00000542-199505000-00009
  17. S.Y. Kim and S.Y. Oh, Iontophoretic Delivery of Vitamine C 2-phosphate, J. Kor. Pharm. Sci., 34,.201-207 (2004)
  18. A. Sieg, R.H. Guy and M.B. Delgado-Charro, Reverse iontophoresis for noninvasive glucose monitoring, The Internal Standard Concept, 92, 2295-2302 (2003)
  19. P. Singh and H.I. Maibach, Iontophoresis in drug delivery: basic principles and applications, Crit. Rev. Ther. Drug Carrier Syst., 11, 161-213 (1994)
  20. R,R. Bumette and T.M. Bagniefski, Influence of constant current iontophoresis on the impedance and passive Na+ permeability of excised mouse skin, J. Pharm. Sci., 77, 492-497 (1988) https://doi.org/10.1002/jps.2600770606
  21. S.Y. Oh and R.H. Guy, Effect of iontophoresis on the electrical properties of human skin in vivo, Int. J. Pharm., 124, 137-142 (1995) https://doi.org/10.1016/0378-5173(95)00180-Q
  22. S.Y. Oh and R.H. Guy, Effect of enhancers on the electrical properties of skin: The effect of Azone and ethanol, J. Kor. Pharm. Sci., 24, S41-S47 (1994)
  23. S.Y. Oh and R.H. Guy, The effect of oleic acid and propylene glycol on the electrical properties of skin, J. Kor. Pharm. Sci., 24, 281-287 (1994)
  24. S.C. Chi and H.W. Jun, Anti-inflammatory activity of ketoprofen gel on carrageenan induced paw edema in rats, J. Pharm. Sci., 79, 974-977 (1990) https://doi.org/10.1002/jps.2600791106
  25. G.R. Hanson, Analgesic, antipyretic and anti-inflammatory drug, In Remington: The Science and practice of pharmacy, 19th Ed., A.R. Gennaro (Ed.), Mack Publishing Company, Easton, U.S.A., p. 1214 (1995)
  26. J. Jacobs A.G. Golstein, M.E. Kelly and B.S. Bloom, NSAIDs dosing schedules and compliance, Drug Intell. Clin. Pharm., 22, 726-727 (1988)
  27. M.F. Cuthbert, Adverse reactions to non-steroidal antirheumatic drugs, Curr. Med. Res. Opin., 2, 600-609 (1974) https://doi.org/10.1185/03007997409115265
  28. K. Sugibayashi, K. Nakayama, T. Seki, K. Hosoya and Y. Morimoto, Mechanism of skin penetration-enhancing effect by laurocapram, J. Pharm. Sci., 81, 58 (1992) https://doi.org/10.1002/jps.2600810112
  29. S.l. Yum, Permeation enhancement with ethanol : In Drug permeation enhancement, Hsieh, D.S. (Ed.), Marcel Dekker: New York, U.S.A., pp. 3-17 (1994)
  30. T. Yamamoto and Y. Yamamoto, Electrical properties of the epidermal stratum corneum, Med. Biol. Eng., March, 151-158 (1976)
  31. E.R. Scott, H.S. White and J.B. Phipps, Direct imaging of ionic pathways in stratum corneum using scanning electrochemical microscopy, Solid State Ionics, 53-56, 176-183 (1992)
  32. C. Cullander and R.H. Guy, Sites of iontophoretic current flow into the skin: Identification and characterization with the vibrating probe electrode, J. Invest. Dermatol., 97, 55-64 (1991) https://doi.org/10.1111/1523-1747.ep12478060
  33. R.R. Burnette and B. Ongpipattanakul, Characterization of the pore transport properties and tissue alteration of excised hwnan skin during iontophoresis, J. Pharm. Sci., 76, 765-773 (1987) https://doi.org/10.1002/jps.2600761003
  34. S.Y. Oh, L. Leung, D. Bommannan, R.H. Guy and R.O. Potts, Effect of current, ionic strength and temperature on the electrical properties of skin, J. Controlled Release, 27, 115-125, (1993) https://doi.org/10.1016/0168-3659(93)90215-Q
  35. S.D. Roy, E. Roos and K. Sharma, Transdermal delivery of buprenorphine through cadaver skin, J. Pharm. Sci., 83(2), 126-30 (1994) https://doi.org/10.1002/jps.2600830204
  36. H.S. Gwak, I.K. Chun, Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin, Int. J. Pharm., 236, 57-64 (2002) https://doi.org/10.1016/S0378-5173(02)00009-1
  37. J. Jona, J. Audett and N. Singh, Transdermal patch and method for administering 17-deacetyl norgestirnate alone or in combination with an estrogen, United States Patent: 6,071,531

Cited by

  1. Modulation of Electroosmotic Flow through Skin: Effect of Poly(Amidoamine) Dendrimers vol.26, pp.2, 2018, https://doi.org/10.4062/biomolther.2017.203